In 2023, the pharmaceutical industry’s export market share for Belgium was recorded at 6.64%. According to the forecasted data, the share is expected to edge upwards marginally to 6.65% in 2024, maintaining a consistent slight increase to 6.66% from 2025 onwards through 2028. This shows a negligible year-on-year variation, suggesting a period of stabilization.

From 2022 to 2023, the variation was a minimal increase of 0.15% (6.64% vs 6.63%). However, the compound annual growth rate (CAGR) over the five-year forecast period projects a flat growth rate, indicating that Belgium's pharmaceutical industry might have reached a saturation point in terms of export market share.

Future trends to watch for:

Impact of new pharmaceutical regulations within the EU.
Emerging markets outside the traditional EU and US markets.
Technological advancements and innovations in pharmaceuticals which could drive demand.
Global health emergencies that could surge demand unpredictably.
Shifts in international trade policies and their implications on the export landscape.